Delgocitinib ointment in pediatric patients with atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study

被引：0

作者：

Nakagawa, Hidemi ^{[1
]}

Nemoto, Osamu ^{[2
]}

Igarashi, Atsuyuki ^{[3
]}

Saeki, Hidehisa

Kabashima, Kenji ^{[4
,5
]}

Oda, Manabu ^{[6
]}

Nagata, Takeshi ^{[6
]}

机构：

[1] Jikei Univ, Sch Med, Tokyo, Japan

[2] Kojinkai Sapporo Skin Clin, Tokyo, Japan

[3] NTT Med Ctr Tokyo, Dept Dermatol, Tokyo, Japan

[4] Nippon Med Sch, Dept Dermatol, Tokyo, Japan

[5] Kyoto Univ, Grad Sch Med, Dept Dermatol, Tokyo, Japan

[6] Japan Tobacco Inc, Pharmaceut Div, Tokyo, Japan

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

25094

引用

页码：AB52 / AB52

页数：1

共 50 条

[1] Delgocitinib ointment in pediatric patients with atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study
Nakagawa, Hidemi
Nemoto, Osamu
Igarashi, Atsuyuki
Saeki, Hidehisa
Kabashima, Kenji
Oda, Manabu
Nagata, Takeshi
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (04) : 854 - 862
[2] Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study
Nakagawa, Hidemi
Nemoto, Osamu
Igarashi, Atsuyuki
Saeki, Hidehisa
Kaino, Hironobu
Nagata, Takeshi
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (04) : 823 - 831
[3] Safety, efficacy, and pharmacokinetics of delgocitinib ointment in infants with atopic dermatitis: A phase 3, open-label, and long-term study
Nakagawa, Hidemi
Igarashi, Atsuyuki
Saeki, Hidehisa
Kabashima, Kenji
Tamaki, Tomomi
Kaino, Hironobu
Miwa, Yasushi
ALLERGOLOGY INTERNATIONAL, 2024, 73 (01) : 137 - 142
[4] Difamilast ointment in adult patients with atopic dermatitis: A phase 3 randomized, double-blind, vehicle-controlled trial
Saeki, Hidehisa
Ito, Kensuke
Yokota, Daisuke
Tsubouchi, Hidetsugu
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (03) : 607 - 614
[5] Prednicarbate 0.25% ointment in the treatment of atopic dermatitis: A vehicle-controlled double-blind study
Lawlor, F
Black, AK
Greaves, M
JOURNAL OF DERMATOLOGICAL TREATMENT, 1995, 6 (04) : 233 - 235
[6] A phase 3 double-blind, randomized, vehicle-controlled study of desonide foam in pediatric and adolescent patients with mild to moderate atopic dermatitis
Friedlander, SF
Loss, R
Schlessinger, J
Potts, A
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB85 - AB85
[7] Difamilast Ointment in Japanese Adult and Pediatric Patients with Atopic Dermatitis: A Phase III, Long-Term, Open-Label Study
Saeki, Hidehisa
Imamura, Tomomi
Yokota, Daisuke
Tsubouchi, Hidetsugu
DERMATOLOGY AND THERAPY, 2022, 12 (07) : 1589 - 1601
[8] Difamilast Ointment in Japanese Adult and Pediatric Patients with Atopic Dermatitis: A Phase III, Long-Term, Open-Label Study
Hidehisa Saeki
Tomomi Imamura
Daisuke Yokota
Hidetsugu Tsubouchi
Dermatology and Therapy, 2022, 12 : 1589 - 1601
[9] Efficacy and safety of topical delgocitinib (JTE-052), janus kinase inhibitor, in Japanese pediatric patients with atopic dermatitis: A phase II, randomized, double-blind, vehicle-controlled study
Nakagawa, Hidemi
Nemoto, Osamu
Igarashi, Atsuyuki
Saeki, Hidehisa
Kabashima, Kenji
Oda, Manabu
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB53 - AB53
[10] Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: Results from a randomized, double-blind, vehicle-controlled study
Schachner, LA
Lamerson, C
Sheehan, MP
Boguniewicz, M
Mosser, J
Raimer, S
Shull, T
Jaracz, E
PEDIATRICS, 2005, 116 (03) : E334 - E342

← 1 2 3 4 5 →